FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

518 letters match. Newest first.

  1. TITAN SARMS LLC

    Titan SARMS LLC sells SARM capsules (LGD-4033, RAD-140, S-4, YK-11) as unapproved new drugs, FDA says after website review.

    High risk
  2. Musclepower Enterprise Ltd. dba MONSTER KING and GE LABS

    FDA warned Musclepower Enterprise (MONSTER KING/GE LABS) over unapproved SARM drugs and undeclared trendione in GE Labs Ykarine.

    High risk
  3. BioXtek LLC

    FDA says BioXtek's amniotic membrane products are unapproved new drugs and unlicensed biological products.

    High risk
  4. VarunKart Group LLC dba Organic Wellnesses

    VarunKart Group sells unapproved Ayurvedic and homeopathic drugs with serious disease claims.

    High risk
  5. Distacart Inc.

    FDA says Distacart's website sells unapproved drugs, some claimed for malaria, asthma, depression and eye conditions.

    High risk
  6. Swift Digital Group LLC dba Swadesii

    FDA warned Swadesii that its website sells unapproved drugs with claims to treat serious conditions including measles, cancer and Alzheimer's.

    High risk
  7. Handelnine Global, LLC dba Navafresh

    Navafresh sells unapproved Ayurvedic drugs online, and its Rheumacare Capsules contain about 7,000 times the lead level of concern.

    High risk
  8. Mahita LLC dba PushMyCart

    FDA told online seller PushMyCart its website and Facebook posts sell unapproved drugs claiming to treat measles, cancer, diabetes and Parkinson's.

    High risk
  9. 123Herbals

    FDA warned 123Herbals that SILINTAN and other herbal products are unapproved drugs, and SILINTAN contains hidden meloxicam.

    High risk
  10. Shoplet

    FDA warned Shoplet over website sales of unapproved, misbranded triclosan antiseptic lotion soaps.

    Medium
  11. Medical Mega

    FDA: Medical Mega sells unapproved triclosan antiseptic soaps as nonprescription drugs.

    Medium
  12. Sinsin Pharmaceutical Co., Ltd.

    FDA warned Sinsin Pharmaceutical that two Korean topical pain relievers sold in the US are unapproved and misbranded drugs.

    High risk
  13. DermaRite Industries, LLC

    DermaRite failed CGMP and sold unapproved, misbranded OTC topical drugs, FDA says.

    High risk
  14. Uriel Pharmacy, Inc.

    Uriel Pharmacy's homeopathic ampule drugs are unapproved new drugs and were made under serious CGMP violations.

    High risk
  15. Korea Filler Experts

    FDA warned Korea Filler Experts that its website sells unapproved and misbranded injectable botulinum toxin drugs, including Nabota 100UI, to U.S. consumers.

    High risk
  16. IBSPOT.com Inc.

    FDA says IBSPOT.com sold unapproved motion sickness patches containing diphenhydramine and diclofenac that the labels never listed.

    High risk
  17. Cosmenic

    FDA warned Panama-based Cosmenic that its website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers.

    High risk
  18. Dermacare dba Filler Outlet

    South Korea's Dermacare, doing business as Filler Outlet, sells unapproved, misbranded injectable botulinum toxin to U.S. consumers through its website.

    High risk
  19. Maypharm

    Maypharm website sells unapproved, misbranded Botulax botulinum toxin to U.S. consumers, FDA says.

    High risk
  20. Estaderma

    FDA warned South Korea's Estaderma that its website sells unapproved, misbranded injectable botulinum toxin (Liztox) to U.S. consumers.

    High risk
  21. Korean Aesthetic dba Korean Fillers

    FDA warned Korean Fillers that its website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers.

    High risk
  22. CelestaPro

    FDA told CelestaPro its website sells unapproved, misbranded injectable botulinum toxin drugs, including "Nabota 200 Unit", to U.S. consumers.

    High risk
  23. AceCosm

    AceCosm’s website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers, FDA says.

    High risk
  24. Dermax Co., Ltd

    FDA warned China's Dermax Co., Ltd. over its website selling unapproved, misbranded injectable botulinum toxin to U.S. consumers.

    High risk
  25. Glow Nest Beauty

    FDA warned Glow Nest Beauty that its website sells unapproved, misbranded injectable botulinum toxin Rentox 200U.

    High risk
  26. Aesthetic Essentials Limited

    Hong Kong company Aesthetic Essentials Limited sells not-FDA-approved, mislabeled injectable botulinum toxin drugs online to U.S. consumers.

    High risk
  27. Elle Pharm

    FDA warned Elle Pharm that its website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers.

    High risk
  28. COSMO KOREA

    FDA told South Korea's COSMO KOREA that its website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers.

    High risk
  29. Glam Derma

    FDA warns Glam Derma over website selling unapproved, misbranded injectable botulinum toxin products.

    High risk
  30. Meamo

    Meamo's website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers, FDA says.

    High risk
  31. MJS Medicals

    FDA warned South Korea's MJS Medicals for selling unapproved, misbranded botulinum toxin ("Innotox") to U.S. consumers online.

    High risk
  32. Derma Solution

    FDA warned Derma Solution for selling unapproved, misbranded injectable Botulax botulinum toxin drugs online to U.S. consumers.

    High risk
  33. Glowface

    Glowface's website sells unapproved, misbranded injectable Botulax botulinum toxin drugs to U.S. consumers, FDA says.

    High risk
  34. onlineotcmeds.com

    FDA warned onlineotcmeds.com for selling unapproved, misbranded opioids, benzodiazepines, and Schedule II stimulants to U.S. consumers online.

    High risk
  35. www.usmedschoice.com

    FDA warned www.usmedschoice.com for selling unapproved and misbranded opioids, benzodiazepines, and stimulants online without prescriptions.

    High risk
  36. Health and Natural Beauty USA Corp.

    FDA warns Health and Natural Beauty USA over CGMP failures and unapproved, misbranded SprinJene OTC toothpastes, including children’s products.

    High risk
  37. New Life Medical Services, LLC

    FDA says New Life Medical Services sells unapproved umbilical-cord, amniotic-fluid, and exosome products as drugs.

    High risk
  38. Dixon Investments Inc. dba ARI

    FDA cites Dixon Investments (ARI) for manufacturing-rule and unapproved/misbranded OTC aerosol drug violations.

    High risk
  39. Persōn & Covey, Inc.

    FDA cites Persōn & Covey for CGMP failures at its Glendale, CA drug plant and for selling unapproved Xerac AC and Drysol.

    High risk
  40. Time Challenger Labs International, Inc.

    Time Challenger Labs was warned for unapproved drug claims on five supplements and serious manufacturing violations.

    High risk
  41. Stellalife, Inc.

    FDA told Stellalife its homeopathic oral care gels and rinses are unapproved new drugs sold without FDA approval.

    High risk
  42. motionpharmacy.com

    FDA warns motionpharmacy.com over selling unapproved and misbranded prescription drugs online.

    High risk
  43. PureRawz

    FDA warns PureRawz its tianeptine products are unapproved new drugs sold with drug claims.

    High risk
  44. GenLabMeds

    GenLabMeds offered compounded retatrutide, semaglutide and tirzepatide online as unapproved, misbranded drugs with false or misleading claims.

    High risk
  45. MedClub by Dr. Jenn

    FDA warns MedClub by Dr. Jenn over unapproved compounded retatrutide and misleading semaglutide claims on its website.

    High risk
  46. ASN-LABS

    ASN-LABS marketed unapproved compounded retatrutide and misleading semaglutide claims online, FDA says.

    High risk
  47. NuVida Medical LLC

    FDA says NuVida Medical sells unapproved, unlicensed tissue products for non-homologous wound care uses.

    High risk
  48. Mericon Industries, Inc.

    Mericon Industries sold Florical and Meribin supplements with unapproved drug claims for osteoporosis and serious manufacturing and labeling failures.

    High risk
  49. Green Vitality dba Gr33n

    FDA warned Green Vitality dba Gr33n that its Jimerito Honey Eye Drops are an unapproved new drug sold with disease-treatment claims.

    High risk
  50. My Holistic Honey c/o Shenzhen Qanhai Wanb Express Supply Chain Co., LTD

    FDA warned My Holistic Honey that its honey eye drops are an unapproved new drug sold with drug claims.

    High risk